2023 Horizon Europe call to support the EU Cancer Mission
Apply for the 2023 HorizonEU call under the EU Cancer Mission to improve cancer research, prevention, diagnostics and patients' quality [...]
Call for projects – PANCREAS 2023
As a continuation of its scientific strategy initiated in 2022 to support research on pancreatic cancer, and following the success [...]
Launch of the 12th Bristol Myers Squibb Foundation call for proposals for research in immuno-oncology
The Bristol Myers Squibb Foundation announces the launch of its 12th call for proposals for research in immune oncology, open [...]
BIPER THERAPEUTICS RAISES €1.25 MILLION
BiPer Therapeutics, awarded during OUI (Oncology Upward Investment) 2021 edition of MEET2WIN raises €1.25 million in seed funding to develop [...]
Partnership MATWIN and European Health Investor Network
MATWIN and the European Health Investor Network announce their new partnership to maximise the investment potential of innovative startups in [...]
Genoscience Pharma receives FDA orphan drug designation for ezurpimtrostat to treat hepatocellular carcinoma
Genoscience Pharma, supported by MATWIN in 2021, receives FDA orphan drug designation for ezurpimtrostat to treat hepatocellular carcinoma. Download the [...]
First US leukemia patient dosed with investigational SMART101 cell therapy
Smart Immune announced today that the first adult leukemia patient has been dosed with SMART101, a T-cell progenitor cell injection [...]
Brenus Pharma and InSphero receive €1.5 million in grants for the collaborative project “STC-1010”
Brenus Pharma, a biotech company specialized in the development of new generations of allogeneic cell-based immunotherapies supported by MATWIN in [...]
Genoscience Pharma announces the start of GNS561’s Phase 2b Clinical Trial
Genoscience Pharma announces launch of phase 2b clinical trial of ezurpimtrostat (GNS561) to treat hepatocarcinoma in combination with an immune [...]
EverImmune launches phase I clinical trial for its oncobiotic drug candidate in lung and kidney cancer
EverImmune supported by MATWIN in 2022 and interviewed by the MATWIN Board launches a phase I clinical trial for its [...]
MPC Therapeutics announces completion of its CHF 1.5M seed-funding round to improve CAR-T cancer therapies.
MPC Therapeutics supported by MATWIN in 2022 and awarded by MATWIN International Board for the "Best Technological Innovation" announces completion of [...]
Smart Immune and Greater Paris University Hospitals (AP-HP) begin groundbreaking Phase I/II trial with ProTcellTM, a thymus-empowered T-cell therapy platform, in adults with blood cancersSmart Immune and Greater Paris University Hospitals (AP-HP) begin groundbreaking Phase I/II trial with ProTcellTM, a thymus-empowered T-cell therapy platform, in adults with blood cancers
Smart Immune and Greater Paris University Hospitals (AP-HP) begin groundbreaking Phase I/II trial with ProTcellTM, a thymus-empowered T-cell therapy platform, in adults with blood cancers
Smart Immune supported by MATWIN in 2022 and awarded “ Best Therapeutic Innovation” by MATWIN International Board launches a Phase I/II trial in adults with [...]
Interview with Karine ROSSIGNOL, CEO Smart-Immune, MATWIN 2022 winner “Best therapeutic innovation”
Introduce us SMARTIMMUNE in a few words Smart Immune, a clinical-stage biotechnology company, is developing a cell therapy platform called [...]
International Cancer Cluster Showcase 2022
MATWIN is a partner of the 10th International Cancer Cluster Showcase, international event showcase of innovation in oncology traditionally backed by the [...]
MATWIN highlights many innovative projects to tackle cancer
Following the 7th edition of MEET2WIN, our [...]
50th Fondation ARC Léopold Griffuel Award
The Fondation ARC Léopold Griffuel Award is one of the most prestigious prize in the field of cancer research in [...]
Cancer Grand Challenges
Cancer Grand Challenges: a global funding platform to solve the toughest problems in cancer research, founded by Cancer Research UK and the [...]
Call for application PPA IMI Innovative Medicine Initiative – April 21
The Innovative Medicines Initiative (IMI) is the result of a partnership between the European Union (EU), represented by the European [...]
Call for projects Oncoentrepreneur program
As part of its mission to raise awareness and development of business creation, Cancer Campus launched in 2014 "OncoEntrepreneur". Specific [...]
Call for projects Onconumérique Program
OncoNumérique initiated by the Cancer Campus biocluster in partnership with Creative Valley is a thematic version and an extension of [...]
CDK4PPI awarded « 2019 best academic project » by the MATWIN international board
CDK4PPI awarded « 2019 best academic project » by the MATWIN international board CDK4 kinase is a key cell cycle [...]
MATWIN’s call for applications
MATWIN is a French open-innovation platform supporting translational innovation in oncology in order to shorten the timeframe for transferring innovations [...]
Invectys awarded « 2019 best project – start-up category » by the MATWIN international Board
Invectys awarded « 2019 best project – start-up category » by the MATWIN international Board Invectys exploits two complementary technological [...]
BPI Call for Projects “Innovation Competition – Growth”
The "Innovation Competition - Growth" call for projects is a support mechanism funded by the Investments for the Future Program [...]